Seeger Weiss Blog
Seeger Weiss Blog: Legal News and Analysis

Archives : 2011 : June

Interview with Hot Coffee Director Susan Saladoff

June 28th, 2011

‎Hot Coffee looks at the stories of four people whose lives were devastated when they were denied access to the courtroom after being injured. Democracy Now! interviews the film’s director Susan Saladoff.

HBO Documentary Hot Coffee – Official Trailer

June 28th, 2011

This is a great documentary about how corporations spend millions to alter the U.S. Civil Justice System, and the uphill battle plaintiffs’ bar and consumers face to get their day in court.

Birth control pills under FDA review over risk of blood clot

June 2nd, 2011

Baltimore Sun:

Blood clots are a well-known risk of taking birth control pills. Now the FDA is investigating oral contraceptives that contain drospirenone, such as Yaz and Yasmin, after new research suggests that these pills increase the risk of blood clots above that of other oral contraceptives.

Most birth control pills combine estrogen with another female sex hormone, progestin. In two studies published in the British Medical Journal in April, pills containing drospirenone, a type of progestin, were found to carry a two- to three-fold higher risk of venous thromboembolism, or a blood clot in a deep vein, than pills containing a different progestin, levonorgestrel.

FDA investigates possible increased blood clot risk from some new birth control pills

June 2nd, 2011

Washington Post:

The FDA said it was “aware of two newly published studies” that found what appeared to be an increased risk for venous thromboembolism (VTE)—blood clots— in women taking birth control pills containing the synthetic version of the hormone progestin called drospirenone. Older birth control pills tend to contain a version of progestin called levonorgestrel.

“This risk is reported to be up to two to three times greater than the risk of VTE associated with using levonorgestrel-containing pills,” the FDA said.

Among the pills containing drospirenone are Yaz, which is sold generically as Gianvi and Loryna; Yasmin, which is sold generically as Ocella, Syeda and Zarah; and Beyaz and Safyral.